POLSKIE TOWARZYSTWO ENDOKRYNOLOGII ONKOLOGICZNEJ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
POLSKIE TOWARZYSTWO ENDOKRYNOLOGII ONKOLOGICZNEJ
Contacts
Registered address
Copy
Website
WWW.PTEO.ORG.PL
Not calculatedReliability
Prescore cannot be calculated – need expert evaluation.
Incorporation date
01/08/2017Share capital
No dataPrimary activity
No dataRepresentatives
0Representatives rights
OŚWIADCZENIE W IMIENIU TOWARZYSTWA MA PRAWO SKŁADAĆ KAŻDY CZŁONEK PREZYDIUM ZARZĄDU (PREZES, WICEPREZES, SEKRETARZ, SKARBNIK) JEDNOOSOBOWO LUB DWÓCH CZŁONKÓW ZARZĄDU ŁĄCZNIE, W ZAKRESIE ZOBOWIĄZAŃ, KTÓRE POCIĄGAĆ MOGĄ ZA SOBĄ SKUTKI FINANSOWE WYMAGANY JEST PODPIS PREZESA LUB SKARBNIKA DO KWOTY 100.000 ZŁ ORAZ PREZESA I SKARBNIKA LUB CO NAJMNIEJ TRZECH CZŁONKÓW ZARZĄDU PRZY KWOTACH POWYŻEJ 100.000 ZŁ.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
-Net Profit (zł)
-Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2023 |
|---|
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| 2024 |
|---|
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| 2025 |
|---|
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| 2025 |
|---|
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
Turnover (zł)
2025
Turnover (zł)
-Profit before tax (zł)
-Net Profit (zł)
-Working capital requirement (%)
-Liquidity ratio
-Net profitability (%)
-Equity (zł)
-Current liabilities (zł)
-Non current liabilities (zł)
-Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
POLSKIE TOWARZYSTWO ENDOKRYNOLOGII ONKOLOGICZNEJ Documents
Date | Description |
|---|---|
- | - |